CDK2 and synovial sarcoma: Consistent with the inhibition of G1-to-S phase progression, we found decreased cyclin D1 expression and decreased phosphorylation of CDK4 and CDK2 in synovial sarcoma cells in response to SAHA, LBH-589, and PXD101.